Impact of tenofovir-containing triple antiretroviral therapy (ART) on bone mineral density in HIV-infected breastfeeding women in sub-Saharan Africa | Dr. L. Stranix

International Workshop on HIV & Pediatrics 2016

Option B+: Beyond ART – Experience with Retention and Outcomes | Landon Myer

International Workshop on HIV & Pediatrics 2016

The Challenge of Drug-Resistant TB in Children with HIV | Simon Schaaf, MMed, PhD

International Workshop on HIV & Pediatrics 2016

Lung function in HIV-infected South African adolesents on antiretroviral therapy: the Cape Town adolescent antiretroviral cohort | Dr. L. Githinji

International Workshop on HIV & Pediatrics 2016

Neuropsychological performance in African HIV children in a multi-site ARV clinical trial is poorer than non-infected children | Dr. M. Boivin

International Workshop on HIV & Pediatrics 2016

Pediatric HIV Treatment and Prevention: From Then to Now | Peter Mugyenyi, MB ChB, FRCPI, FRCP

International Workshop on HIV & Pediatrics 2016

New WHO Guidelines on Breastfeeding | Nigel Rollins

International Workshop on HIV & Pediatrics 2016

Pediatric Drug Pipeline: New Drugs, New Strategies | Martina Penazzato, MD, DTMH, MSc, PhD

International Workshop on HIV & Pediatrics 2016

Testing at Birth – Update from South Africa | Gayle Sherman

International Workshop on HIV & Pediatrics 2016

Virological response and resistance among HIV-infected children on first-line antiretroviral therapy without routine virological monitoring | Dr. Andrew Prendergast

International Workshop on HIV & Pediatrics 2016

UNICEF Consultation: Countries Implementation of B+ | Chewe Luo, MD, PhD

International Workshop on HIV & Pediatrics 2016

Access to antiretroviral initiation among HIV-infected children aged 0-19 years in the International Epidemiologic Databases to Evaluate AIDS Global Network | Dr. V. Leroy

International Workshop on HIV & Pediatrics 2016